Cargando…

Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis

OBJECTIVE: To investigate the efficacy and tolerability of duloxetine during short-term treatment in adults with generalized anxiety disorder (GAD). METHODS: We conducted a comprehensive literature review of the PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xinyuan, Zhu, Lijun, Zhou, Chunkui, Liu, Jing, Du, Heqian, Wang, Chenglin, Fang, Shaokuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860757/ https://www.ncbi.nlm.nih.gov/pubmed/29558528 http://dx.doi.org/10.1371/journal.pone.0194501

Ejemplares similares

Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: A meta-analysis
por: Li, Xinyuan, et al.
Publicado: (2017)

A case of a novel CACNA1G mutation from a Chinese family with SCA42: A case report and literature review
por: Li, Xinyuan, et al.
Publicado: (2018)

Short-Term Efficacy and Tolerability of Paroxetine Versus Placebo for Panic Disorder: A Meta-Analysis of Randomized Controlled Trials
por: Zhang, Beilin, et al.
Publicado: (2020)

Efficacy and tolerability of paroxetine in adults with social anxiety disorder: A meta-analysis of randomized controlled trials
por: Li, Xinyuan, et al.
Publicado: (2020)

Duloxetine in the treatment of generalized anxiety disorder
por: Norman, Trevor R, et al.
Publicado: (2008)

Duloxetine in the treatment of generalized anxiety disorder
por: Wright, Alan, et al.
Publicado: (2009)

Duloxetine for the treatment of generalized anxiety disorder: a review
por: Khan, Ahsan Y, et al.
Publicado: (2009)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

The role of duloxetine in the treatment of anxiety disorders
por: De Berardis, Domenico, et al.
Publicado: (2008)

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

Prevalence and geographical variation of Factor V Leiden in patients with cerebral venous thrombosis: A meta-analysis
por: Li, Xinyuan, et al.
Publicado: (2018)

On-admission serum uric acid predicts outcomes after acute myocardial infarction
por: Zhou, Chunkui, et al.
Publicado: (2012)

Dystrophia myotonica type 1 presenting with dysarthria: A case report and literature review
por: Li, Chunrong, et al.
Publicado: (2017)

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial
por: Alaka, Karla J, et al.
Publicado: (2014)

Efficacy and tolerability of fluvoxamine in adults with social anxiety disorder: A meta-analysis
por: Liu, Xue, et al.
Publicado: (2018)

The short-term effect and safety of duloxetine in osteoarthritis: A systematic review and meta-analysis
por: Gao, Shi-Hua, et al.
Publicado: (2019)

Magnetic resonance diffusion tensor imaging for occult lesion detection in multiple sclerosis
por: Chen, Jiafeng, et al.
Publicado: (2017)

The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway
por: Zhang, Beilin, et al.
Publicado: (2019)

A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder
por: Szekeres, Gyorgy, et al.
Publicado: (2021)

The anterior cingulate cortex contributes to the analgesic rather than the anxiolytic effects of duloxetine in chronic pain-induced anxiety
por: Li, Chenglin, et al.
Publicado: (2022)

Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: A network meta-analysis
por: Duan, Hanying, et al.
Publicado: (2022)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Baseline depressive symptoms as predictors of efficacy and tolerability of the treatment with duloxetine: a network analysis approach
por: Maciaszek, Julian, et al.
Publicado: (2023)

Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder
por: Zhu, Junliang, et al.
Publicado: (2022)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
por: Harada, Eiji, et al.
Publicado: (2016)

Efficacy of Duloxetine in Patients with Chronic Pain Conditions
por: Skljarevski, Vladimir, et al.
Publicado: (2011)

Duloxetine in panic disorder with somatic gastric pain
por: Preve, Matteo, et al.
Publicado: (2013)

EFFICACY OF MEDITATION IN GENERALIZED ANXIETY DISORDER
por: Vahia, Vihang N., et al.
Publicado: (1993)

Effect of a combination of duloxetine with hydroxyzine on experimental models of anxiety in mice
por: Patel, Sonam, et al.
Publicado: (2015)

Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
por: Cheon, Eun-Jin, et al.
Publicado: (2016)

Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis
por: Osani, Mikala C., et al.
Publicado: (2019)

The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity
por: Wise, T N, et al.
Publicado: (2007)

Evaluation of efficacy of duloxetine in stress urinary incontinence in women
por: Deepak, P., et al.
Publicado: (2011)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
por: Harada, Eiji, et al.
Publicado: (2015)

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
por: Mallinckrodt, Craig H, et al.
Publicado: (2005)

The Effect of Food on the Single‐Dose Bioavailability and Tolerability of the Highest Marketed Strength of Duloxetine
por: Rizea‐Savu, Simona, et al.
Publicado: (2019)

Duloxetine hydrochloride
por: Bhadbhade, Mohan, et al.
Publicado: (2009)

Duloxetine induced hyponatremia
por: Kulkarni, M.
Publicado: (2015)

Efavirenz restored NMDA receptor dysfunction and inhibited epileptic seizures in GluN2A/Grin2a mutant mice
por: Zhao, Teng, et al.
Publicado: (2023)

Duloxetine in the treatment of major depressive disorder: an open-label study
por: Hudson, James I, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ekl2lkicf95h30ko8m7j3ilu24